FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386899002: Atovaquone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461077014 Atovaquone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481013013 Atovaquone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
51701000195118 atovaquone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
792691000172110 atovaquone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65971000195115 Atovaquon de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atovaquone (substance) Is a Antiprotozoal true Inferred relationship Some
Atovaquone (substance) Is a classe d'allergènes false Inferred relationship Some
Atovaquone (substance) Is a allergène médicamenteux false Inferred relationship Some
Atovaquone (substance) Is a Naphthoquinone (substance) true Inferred relationship Some
Atovaquone (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiprotozoal true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing atovaquone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Atovaquone adverse reaction Causative agent (attribute) True Atovaquone (substance) Inferred relationship Some 1
Allergy to atovaquone Causative agent (attribute) False Atovaquone (substance) Inferred relationship Some
Atovaquone+proguanil hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atovaquone (substance) Inferred relationship Some
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atovaquone (substance) Inferred relationship Some
Atovaquone 750mg/5mL s/f suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atovaquone (substance) Inferred relationship Some
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atovaquone (substance) Inferred relationship Some
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atovaquone (substance) Inferred relationship Some
Product containing atovaquone and proguanil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Allergy to atovaquone Causative agent (attribute) True Atovaquone (substance) Inferred relationship Some 1
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atovaquone (substance) Inferred relationship Some 2
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Atovaquone (substance) Inferred relationship Some 2
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atovaquone (substance) Inferred relationship Some 2
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Atovaquone (substance) Inferred relationship Some 2
Atovaquone- and proguanil-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Atovaquone (substance) Inferred relationship Some 2
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Atovaquone (substance) Inferred relationship Some 2
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Atovaquone (substance) Inferred relationship Some 1
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Atovaquone (substance) Inferred relationship Some 1
Atovaquone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Product containing only atovaquone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Product containing only atovaquone and proguanil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Atovaquone and proguanil only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Product containing only atovaquone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atovaquone (substance) Inferred relationship Some 1
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Atovaquone (substance) Inferred relationship Some 1
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Atovaquone (substance) Inferred relationship Some 1
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Atovaquone (substance) Inferred relationship Some 1
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Atovaquone (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start